Cannara Biotech (STU:8CB0) Price-to-Operating-Cash-Flow : 7.45 (As of Jun. 21, 2024)

View and export this data going back to 2019. Start your Free Trial

What is Cannara Biotech Price-to-Operating-Cash-Flow?

As of today (2024-06-21), Cannara Biotech's share price is €0.462. Cannara Biotech's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Feb. 2024 was €0.06. Hence, Cannara Biotech's Price-to-Operating-Cash-Flow Ratio for today is 7.45.

The historical rank and industry rank for Cannara Biotech's Price-to-Operating-Cash-Flow or its related term are showing as below:

STU:8CB0' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 7.67 Med: 15.67 Max: 77.78
Current: 7.67

During the past 6 years, Cannara Biotech's highest Price-to-Operating-Cash-Flow Ratio was 77.78. The lowest was 7.67. And the median was 15.67.

STU:8CB0's Price-to-Operating-Cash-Flow is ranked better than
79.3% of 681 companies
in the Drug Manufacturers industry
Industry Median: 15.95 vs STU:8CB0: 7.67

Cannara Biotech's Cash Flow from Operations per share for the three months ended in Feb. 2024 was €0.02. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Feb. 2024 was €0.06.

During the past 6 years, Cannara Biotech's highest 3-Year average Operating Cash Flow per Share Growth Rate was 17.10% per year. The lowest was -16.70% per year. And the median was 0.20% per year.

Cannara Biotech Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Cannara Biotech's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cannara Biotech Price-to-Operating-Cash-Flow Chart

Cannara Biotech Annual Data

Trend

Aug18

Aug19

Aug20

Aug21

Aug22

Aug23

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

16.39

Cannara Biotech Quarterly Data
	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial															-	-	16.39	11.91	10.89

Competitive Comparison of Cannara Biotech's Price-to-Operating-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, Cannara Biotech's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cannara Biotech's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cannara Biotech's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Cannara Biotech's Price-to-Operating-Cash-Flow falls into.

Cannara Biotech Price-to-Operating-Cash-Flow Calculation

Cannara Biotech's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	0.462	/	0.062
	=	7.45

Cannara Biotech's Share Price of today is €0.462.
Cannara Biotech's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.06.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Cannara Biotech Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Cannara Biotech's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Cannara Biotech (STU:8CB0) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cannara Biotech Inc (STU:8CB0) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

LOVFF:USA LOVE:Canada

Address

1055 West Georgia Street, Suite 2050, Vancouver, BC, CAN, V6E 3P3

Website

http://www.cannara.ca

Cannara Biotech Inc is a vertically integrated producer of premium-grade cannabis and cannabis-derivative products for Canadian markets. The company owns two mega Quebec-based facilities. The company operates in in two segments; Indoor cannabis operations segment which includes the cultivation, processing and sale of dried cannabis and cannabis derivatives for the Canadian market and the Real estate operations segment related to the Farnham and Valleyfield building. Majority of the revenue for the company is generated from its Cannabis operations segment. .

Cannara Biotech (STU:8CB0) Headlines

No Headlines